Feedback
The current prices are delayed. Login to see live prices.

UltraTech Cement Ltd.

(ULTRACEMCO)

1012345678920123456789,301234567897012345678900123456789.0012345678900123456789
+12.00 (+0.10%)
Updated 15:59 17/10 IST
Add
Previous Close: 12358
Today's low
₹12,259.00
Today's high
₹12,390
52 week low
₹9,250
52 week high
₹13,097
Open
₹12,300
Prev Close
₹12,358
Volume (shares)
182,242
Total Trading Value
225.21 Cr

Technicals

SMA
Value
Signal
12-SMA
11,113.99
Bullish
20-SMA
11,240.57
Bullish
50-SMA
11,217.7
Bullish
100-SMA
11,249.39
Bullish
200-SMA
11,233.57
Bullish

Discussions

  •  Oct 15 4:28 PM
ULTRACEMCO 12100 CE
ABOVE 285...read more

1

4
  •  Sep 11 4:54 PM
BTST/INTRADAY/HOLDING
Educational purpose only not to buy sell recommendation as per sebi rules ...read more

1

  •  Sep 17 2:50 PM
📊 Intraday stocks for today 👇🏻
1. TATACONSUM...read more

4

  •  Oct 6 4:43 PM
📊INTRADAY PICK – #ULTRACEMCO 🏗️
🚀CMP: 12,062...read more

1

1
1
  •  Sep 16 2:49 PM
BUY #ULTRACEMCO 12500CE ABOVE 200

1

  •  Sep 30 10:25 PM
NIFTY INTRADAY TRADING LEVELS FOR TOMMORRROW
DATE- `01.10.2025...read more

39

3
13
  •  Oct 15 1:01 AM
FII & DII INCREASE ⬆️
....read more

2

2
1
Load More Posts

Frequently Asked Questions (FAQs)

What is the Share Price of UltraTech Cement Ltd. ?

The share prices are volatile and fluctuate throughout the trading hours. The share price of UltraTech Cement Ltd. is Rs 12358 as of 17 October 2025.

What is the Market Capitalization of UltraTech Cement Ltd. ?

The current market cap of UltraTech Cement Ltd. is undefined Market capitalisation is calculated by multiplying the current share price with the total number of shares.

What are the PE and PB ratios of UltraTech Cement Ltd.?

UltraTech Cement Ltd. has a price-to-earnings (PE) ratio of undefined and a price-to-book (PB) ratio of undefined.

What is the 52-week high/low of UltraTech Cement Ltd.?

The 52-week high of UltraTech Cement Ltd. is Rs 13097 and the 52-week low is Rs 9250
Hero Img
Join 10,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Create your account on Frontpage
DisclaimerPrivacy
FrontPage © 2025